Maintenance Notice (10:30 PM January 4 - 8:00 AM January 5, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 196597-26-9 | 产品编码: R0216
Ramelteon
产品编码 | R0216 |
纯度/分析方法 | >98.0%(GC) |
分子式/分子量 | C__1__6H__2__1NO__2 = 259.35 |
外观与形状(20°C) | 固体 |
储存温度 | 室温 (15°C以下阴凉干燥处) |
包装和容器 | 100MG-Glass Bottle with Plastic Insert (查看图片), 1G-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 196597-26-9 |
Reaxys-RN | 9277585 |
PubChem物质ID | 468592788 |
Merck Index (14) | 8101 |
MDL编号 | MFCD08067736 |
技术规格
Appearance | White to Almost white powder to crystal |
Purity(GC) | min. 98.0 % |
Melting point | 114.0 to 118.0 °C |
Specific rotation [a]20/D | -55.0 to -60.0 deg(C=1, CHCL3) |
物性(参考值)
熔点 | 116 °C |
比旋光度 [α]D | -57° (C=1,CHCl3) |
水溶性 | 不溶 |
在水中的溶解度 | 11 mg/l 25 °C |
溶解性(可溶于) | 乙醇 |
GHS
象形图 | |
信号词 | Warning |
危险性说明 | H302 : Harmful if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
相关法规
RTECS# | TX1498230 |
运输信息
HS编码* | 2932.99-000 |
应用
Ramelteon: A Selective Melatonin MT1 and MT2 Receptors Agonist
Ramelteon (TAK-375) is a melatonin [M1105] receptor agonist with both high affinity for melatonin MT1 and MT2 receptors, and high selectivity for MT1 and MT2 receptors compared to the MT3 receptor. In addition, ramelteon showed no measurable affinity for a large number of ligand binding sites, including benzodiazepine receptors, dopamine receptors, opiate receptors, ion channels, and transporters. Ramelteon also does not interfere with the activity of a number of enzymes. The agonist activity at the MT1 and MT2 receptors has been reported to contribute to its sleep-promoting properties. And then, ramelteon currently is approved in the United States and Japan for the treatment of insomnia. (The product is for research purpose only.)
References
- Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
- Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders (a review)
- Enantiomeric separation of a melatonin agonist Ramelteon using amylose-based chiral stationary phase
- メラトニン受容体作動薬ラメルテオン (ロゼレム®錠8 mg) の薬理作用と臨床試験成績
文章/手册
TCIMail
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。